514
Can. J. Chem. Vol. 90, 2012
m/z calcd for C13H15N5O6 (M+): 337.1022; found: 337.1011.
EIMS m/z: 337(M+), 320, 291, 278, 249, 181, 169, 122, 108,
93, 77, 67, 55.
Experimental
All solvents were distilled prior to use according to standard
procedures. Methylene dichloride was dehydrated with CaH2
by refluxing.
1H and 13C NMR spectra were recorded on a Bruker
Avance 400 (1H, 400 MHz; or 13C, 100 MHz; d downfield
from TMS). IR analysis was performed on a Nicolet NEXUS
670 FT-IR. Mass data were obtained on a HP-5988A GC–
MS, and HR-ESI-MS data were obtained on a Bruker Dalton-
ics APEx II FT-ICR. Melting points were determined with an
XT4-100X micromelting point apparatus and not corrected.
X-ray analysis on single crystals was carried out at 293(2) K
on a Nonius CAD4 automatic diffractometer using graphite-
monochromated Mo Ka radiation (l = 0.710 73 Å). Struc-
tural solutions and full-matrix least-squares refinements
based on F2 were performed with the SHELXS-97 and
SHELXL-97 program packages,21 respectively. All the non-
hydrogen atoms were anisotropically positioned. Hydrogen
atoms were placed in geometrical positions and constrained to
ride on their parent atoms. Analytical expressions of neutral-
atom scattering factors were employed, and anomalous dis-
persion corrections were incorporated (see the Supplemen-
tary data for crystallographic data (excluding structure
factors)).22
(E)-1-(2,4-Dinitrophenyl)-2-((Z)-3-nitro-4-phenylbut-3-en-2-
ylidene)hydrazine (2b)
Orange needles, mp 147–149 °C. 1H NMR (400 MHz,
CDCl3, ppm) d: 2.36 (s, 3H), 7.39–7.49 (m, 5H), 7.23 (d,
J = 9.6 Hz, 1H), 8.20 (s, 1H), 8.26 (dd, J = 9.6, 2.4 Hz,
1H), 9.15 (d, J = 2.4 Hz, 1H), 11.36 (s, 1H). 13C NMR
(100 MHz, CDCl3, ppm) d: 16.7, 116.8, 123.0, 129.4, 130.2,
130.4, 130.6, 131.8, 136.8, 139.4, 144.4, 144.5, 147.1. IR
(KBr, cm–1) nmax: 3308, 3107, 1652, 1615, 1514, 1333,
1139, 1095, 968, 935, 836, 743, 688, 581, 504. HR-ESI-MS
+
m/z calcd for C16H17N6O6 (M + NH4 ): 389.1209; found:
389.1218. EIMS m/z: 371 (M+), 354, 336, 278, 232, 128,
102, 77, 63, 51, 43.
(E)-1-(2,4-Dinitrophenyl)-2-((E)-2-nitro-1,3-
diphenylallylidene)hydrazine (2c)
Orange needles, mp 184–186 °C. 1H NMR (400 MHz,
CDCl3, ppm) d: 7.06–7.33 (m, 10H), 7.68 (d, J = 12.8 Hz,
1H), 8.15 (1H, s), 8.30 (d, J = 12.8 Hz, 1H), 9.03 (s, 1H),
11.38 (1H, s). 13C NMR (100 MHz, CDCl3, ppm) d: 117.1,
119.7, 123.4, 126.1, 127.8, 128.1, 128.6, 129.6, 130.1,
130.6, 131.8, 136.5, 139.4, 144.2, 144.6, 147.7, 155.1. IR
(KBr, cm–1) nmax: 3268, 3080, 2923, 2851, 1613, 1497,
1423, 1333, 1135, 1099, 919, 830, 767, 692, 632, 510. HR-
ESI-MS m/z calcd for C21H15N5O6 (M+): 433.1023; found:
433.1016. EIMS m/z: 433 (M+), 403, 386, 294, 207, 189,
165, 135, 105, 77, 63, 51, 44, 39.
General procedure for the synthesis of 2a–2g
A solution of 1 was prepared by dissolving 1 (0.5 mmol)
in 100 mL of anhydrous dichloromethane. NO was produced
by dropwise addition of 1 mol L–1 H2SO4 solution to a
stirred saturated aqueous solution of NaNO2 under an argon
atmosphere. NO gas was purified by passing through a series
of scrubbing bottles containing 4 mol L–1 NaOH, distilled
water, and anhydrous CaCl2 pellets in this order. The purified
NO was bubbled through the stirred solution of 1, which was
previously degassed by argon for approx. 5–10 min and kept
at a pressure of up to +10 mm H2O column over local at-
mospheric pressure, at ambient temperature for 8–14 h. In
the course of the reaction, the argon flow rate was controlled
by regulating the flow meter at 0.8 L min–1. A rough esti-
mate of the total amount of NO passing through the solution
was about 1000 mmol at the local atmosphere pressure using
the ideal gas law. The progress of the reaction was monitored
by TLC. After the reaction was complete, the mixture was
dried over anhydrous MgSO4, concentrated under vacuum,
and purified by column chromatography on silica gel (200–
300 mesh; ethyl acetate – petroleum ether, 1:6 v/v), giving
pure product 2 (Table 1).
(E)-1-(2,4-Dinitrophenyl)-2-(3-nitrocyclohex-2-enylidene)
hydrazine (2d)
Orange needles, mp 216–217 °C. 1H NMR (400 MHz,
CDCl3, ppm) d: 2.15 (tt, J = 6.4, 6.8 Hz, 2H), 2.64 (t, J =
6.8 Hz, 2H), 2.90 (t, J = 6.4 Hz, 2H), 7.66 (s, 1H), 8.10 (d,
J = 9.6 Hz, 1H), 8.42 (dd, J = 9.6, 2.8 Hz, 1H), 9.16 (d, J =
2.8 Hz, 1H), 11.50 (s, 1H). 13C NMR (100 MHz, CDCl3,
ppm) d: 20.3, 21.2, 22.9, 23.7, 29.7, 116.9, 123.1, 129.6,
130.4, 130.6, 139.6, 143.9, 149.7, 153.5. IR (KBr, cm–1)
nmax: 3302, 3097, 2937, 1614, 1498, 1419, 1313, 1100, 925,
850, 792, 592, 518. HR-ESI-MS m/z calcd for C12H11N5O6
(M+): 321.0709; found: 321.0721. EIMS m/z: 321 (M+),
181, 152, 109, 77, 65, 55, 51, 44, 39.
(E)-1-(2,4-Dinitrophenyl)-2-(3-methyl-2-nitrocyclohex-2-
enylidene)hydrazine (2e)
(E)-1-(2,4-Dinitrophenyl)-2-((Z)-5-methyl-3-nitrohex-3-en-
2-ylidene)hydrazine (2a)
Red needles, mp 214–215 °C. 1H NMR (400 MHz,
CDCl3, ppm) d: 1.98 (s, 3H), 2.04–2.11 (m, 2H), 2.46 (t,
J = 7.2 Hz, 2H), 2.68 (t, J = 8.8 Hz, 2H), 7.83 (d, J =
12.8 Hz, 1H), 8.32 (dd, J = 12.8, 2.4 Hz, 1H), 9.11 (d, J =
2.4 Hz, 1H), 11.20 (s, 1H). 13C NMR (100 MHz, CDCl3,
ppm) d: 19.7, 20.0, 23.7, 30.0, 117.0, 123.3, 130.3, 130.6,
Yellow needles, mp 129–130 °C. 1H NMR (400 MHz,
CDCl3, ppm) d: 1.15(d, 6H, J = 4.6 Hz), 2.30 (s, 3H), 2.67–
2.73 (m, 1H), 7.21 (d, J = 12.8 Hz, 1H), 7.89 (d, J = 9.6 Hz,
1H), 8.39 (dd, J = 9.6, 2.8 Hz, 1H), 9.18 (d, J = 2.8 Hz,
1H), 11.32 (s, 1H). 13C NMR (100 MHz, CDCl3, ppm) d:
16.6, 22.1, 28.4, 63.4, 116.5, 123.2, 130.3, 130.4, 139.2,
144.4, 144.5, 146.9, 147.6. IR (KBr, cm–1) nmax: 3308, 3105,
2973, 2919, 2873, 2848, 1616, 1593, 1501, 1423, 1337,
1136, 1095, 953, 920, 831, 797, 740, 577, 505. HR-ESI-MS
139.1, 139.9, 144.4, 144.6, 146.7. IR (KBr, cm–1) nmax
:
3305, 3105, 2963, 2938, 1611, 1501, 1427, 1333, 1306,
1137, 1113, 1062, 914, 848, 769, 739, 708, 680, 576, 556,
499. HR-ESI-MS m/z calcd for C13H13N5O6Na (M + Na+):
Published by NRC Research Press